Description

Pramistar Tablets 600 mg, #20

Composition

Each tablet of Pramistar contains 600 mg of the active ingredient pramiracetam. Inactive ingredients include microcrystalline cellulose, povidone, sodium starch glycolate, colloidal anhydrous silica, and magnesium stearate.

Description

Pramistar is a nootropic (cognitive-enhancing) medication used to improve memory and cognitive function in patients with cognitive decline, neurodegenerative diseases, or brain injuries. It is a derivative of the racetam family, specifically designed to enhance higher cognitive processes, including learning and recall.

Pharmacological Properties

Pramiracetam acts primarily by modulating the function of the hippocampus through high-affinity choline uptake, enhancing acetylcholine synthesis. This mechanism supports synaptic plasticity and memory formation. Unlike other racetams, pramiracetam does not significantly alter mood or anxiety levels, making it a preferred option for focused cognitive enhancement.

Indications

• Cognitive impairment due to cerebrovascular insufficiency
• Memory and attention disorders in elderly patients
• Traumatic brain injury (TBI) and post-concussion syndrome
• Supportive treatment in mild neurocognitive disorders
• Off-label: cognitive enhancement in healthy individuals (research-based use)

Dosage and Administration

The typical recommended dosage is 600 mg twice daily (morning and evening), taken orally with or after meals. Tablets should be swallowed whole with a glass of water. In cases of hepatic or renal impairment, dosage adjustments may be required under physician supervision.

Contraindications

• Hypersensitivity to pramiracetam or any component of the formulation
• Severe renal impairment
• History of severe psychiatric disorders such as psychosis or suicidal depression
• Pregnancy and breastfeeding (due to lack of safety data)

Warnings and Precautions

Use with caution in patients with mild to moderate renal impairment. Regular monitoring is recommended in long-term users. Patients should be warned against operating heavy machinery or driving until they are certain how Pramistar affects them.

Adverse Reactions

• Common: headache, nausea, insomnia, fatigue
• Less common: agitation, anxiety, dry mouth, dizziness, gastrointestinal discomfort
• Rare: allergic rash, increased libido

Adverse events are usually mild and transient. Discontinue use and consult a physician if symptoms worsen.

Overdose

No specific antidote exists. In the case of overdose, symptomatic and supportive treatment should be provided. Overdose may manifest as exaggerated side effects including severe headache, restlessness, or gastrointestinal upset.

Drug Interactions

Caution is advised when using pramiracetam concurrently with:

• Antiepileptics – may alter seizure threshold
• SSRIs and tricyclic antidepressants – potential CNS effects
• Other nootropics – may lead to cumulative stimulation
• Alcohol – may increase CNS depression and reduce therapeutic benefits

Always inform your physician about all concurrent medications, including supplements.

Storage

Store in a dry place at room temperature (15°C – 25°C), away from light and moisture. Keep the product out of reach of children.

Clinical Research

• Clinical efficacy of pramiracetam in cognitive disorders (PubMed)
• Review of pramiracetam’s neuropharmacology (NCBI)

Packaging

Pramistar tablets come in cartons containing 2 blister packs of 10 tablets each (20 tablets total per package).

Manufacturer

Manufactured by Menarini Group, an international pharmaceutical company committed to high standards of research, development, and manufacturing practices.